India’s Shantha Biotech Draws Interest From MNCs And Universities Alike

MUMBAI - The race to buy an equity stake in India's vaccine maker Shantha Biotechnics is taking a curious turn with a few international academic institutions and universities showing interest in the company's product pipeline and marketed vaccines